- 1. (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide
- [A sulfonamide and carbonic anhydrase inhibitor with specific affinity for carbonic anhydrase II. Following topical ocular administration, brinzolamide inhibits carbonic anhydrase II, an enzyme that is responsible for the movement of sodium and fluid transport in the eye. This inhibition leads to a decrease in aqueous humor secretion, probably by slowing the formation of bicarbonate ions, and results in a reduction in intraocular pressure. Brindazolamide is used to treat increased pressure in the eye caused by open-angle glaucoma. ( NCI )] (UMLS (NCI) C0673966) =Organic Chemical; Pharmacologic Substance =azopt;
[OP104] CARBONIC ANHYDRASE INHIBITORS, SYSTEMIC OPHTHALMIC =BRINZOLAMIDE 1 %;
| - 51. Reticulosarcoma involving spleen
- [ ] (UMLS (ICD9CM) C0153702) =Neoplastic Process
|
- 2. RET
- [This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas. ( NCI )] (UMLS (NCI) C0694890) =Gene or Genome ;
| - 52. Reticulose
- (UMLS (NCI) C0140261) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 3. RET DYSTRPH IN LIPIDOSES
- [ ] (UMLS (ICD9CM) C0154861) =Disease or Syndrome
| - 53. reticulospinal tract
- [any of several tracts whose fibers arise from cells in tegmental or reticular nuclei (reticular formation) of the brain stem and which descend into the spinal cord; these tracts have multiple functions, including motor coordination and the regulation of muscle tone; also regulates autonomic functions mediated through the spinal cord. ( CSP )] (UMLS (CSP) C0175558) =Body Part, Organ, or Organ Component =central neural pathway/tract;
|
- 4. RET DYSTRPH IN SYST DIS
- [ ] (UMLS (ICD9CM) C0154862) =Disease or Syndrome
| - 54. reticulum cell
- [ ] (UMLS (CSP) C0229606) =Cell
|
- 5. RET Finger Protein
- [Encoded by human RFP Gene (TRIM Family), 513-aa 58.5-kDa RET Finger Protein contains a TRIM motif: 3 zinc-binding domains, a RING, a type 1 and type 2 B-box, and a coiled-coil region. Located in the nuclear matrix, RFP interacts with enhancer of polycomb protein, represses gene transcription, and is thought to be involved in male germ cell differentiation. Gene rearrangements with RET produce RET transforming protein, containing the RFP N-terminus with the RET protein tyrosine kinase. (NCI) ( NCI )] (UMLS (NCI) C0084325) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 55. reticulum cell lymphoma
- [ ] (UMLS (CSP) C0865033) =Neoplastic Process
|
- 6. RET Finger Protein 2 Gene
- [This gene may be involved in the negative regulation of cell growth. ( NCI )] (UMLS (NCI) C1367699) RFP2;
RFP2 Gene;
=Gene or Genome | - 56. Retin-A
- (UMLS (NCI) C0593762) =Organic Chemical; Pharmacologic Substance
|
- 7. RET Oncoprotein
- [Human RET Oncoprotein is a product of mutated variants (Oncogene RET) of RET Gene, which encodes Tyrosine-Protein Kinase Receptor RET, a type I membrane protein receptor for Glial Cell Line-Derived with an extracellular cadherin-like domain and important in neural crest development. Some oncogenic RET point mutations cause constitutive kinase activation. PTC1 oncogene involves fusion of RET kinase to the H4 dimerization leucine zipper. In PTC6, RET is fused to the N-terminal part of Transcriptional Intermediary Factor-1-Alpha. In PTC7, RET is fused to a C-terminal part of TIF1-Gamma. Oncogenic RET mutations are associated with Hirschsprung's disease, Multiple Endocrine Neoplasia, pheochromocytoma, hyperparathyroidism and medullary thyroid cancer. RET Oncoprotein disrupts normal cell function. ( NCI )] (UMLS (NCI) C1335613) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 57. Retin-A MICRO
- (UMLS (NCI) C1171295) Retin-A MICRO brand of tretinoin =Organic Chemical; Pharmacologic Substance ;
|
- 8. RET PROD CONC-DEL W P/P
- [ ] (UMLS (ICD9CM) C0157410) =Disease or Syndrome
| - 58. retina circulation
- [vessels, supply, and flow of blood through the vascular system of the retina. ( CSP )] (UMLS (CSP) C0597406) =Organ or Tissue Function ;
=eye circulation;
|
- 9. RET PROD CONCEPT-POSTPAR
- [ ] (UMLS (ICD9CM) C0157411) =Disease or Syndrome
| - 59. retina circulation disorder
- [pathologic condition affecting the movement of blood through the vessels of the retina. ( CSP )] (UMLS (CSP) C0154833) =Disease or Syndrome =eye circulation disorder;
|
- 10. RET/D10S170 Oncogene
- [The PTC1 chimeric oncogene (RET/PTC1, RET/H4) is generated by fusion of the RET proto-oncogene receptor tyrosine kinase domain to the 5-prime terminal region of the H4 gene containing a putative leucine zipper. H4 shows no significant homology to known genes and the protein function is unknown. The RET receptor ligand is Glial Cell Line-Derived Neurotrophic Factor. The putative H4 leucine zipper mediates dimerization of the PTC1 oncoprotein, essential for PTC1 transforming activity. (NCI) ( NCI )] (UMLS (NCI) C0919512) RET/H4 Oncogene;
RET/PTC1 Oncogene;
Transforming Sequence, Thyroid 1;
TST1 Oncogene;
=Gene or Genome ;
| - 60. RETINA EXUDATES/DEPOSITS
- [ ] (UMLS (ICD9CM) C0154867) =Disease or Syndrome
|
- 11. RET/H4 Chimeric Oncoprotein
- [The PTC1 chimeric oncogene (RET/PTC1) is generated by fusion of the RET proto-oncogene receptor tyrosine kinase domain to the 5-prime terminal region of the H4 gene containing a putative leucine zipper. H4 shows no significant homology to known genes and the protein function is unknown. The RET receptor ligand is Glial Cell Line-Derived Neurotrophic Factor. The putative H4 leucine zipper mediates dimerization of the PTC1 oncoprotein, essential for PTC1 transforming activity. (from OMIM 601985 and NCI) ( NCI )] (UMLS (NCI) C1335611) RET/H4 Oncoprotein;
=Amino Acid, Peptide, or Protein; Enzyme | - 61. retina hemorrhage
- [escape of blood from the vessels of the innermost of the three tunics of the eyeball or retina. ( CSP )] (UMLS (CSP) C0035317) =Pathologic Function ;
=Eye Hemorrhage;
bleeding;
ANDRE NETTHINNESYKDOMMER - h35.0;
|
- 12. retailed material
- [Material (player) sold by a retailer (scoper), who also give advice to prospective buyers. ( HL7V3.0 )] (UMLS (HL7) C1550596) =Idea or Concept =distributed material;
| - 62. Retina Layer
- (UMLS (NCI) C0459649) =Body Part, Organ, or Organ Component ;
|
- 13. RETAIN PLAC NOS-POSTPART
- [ ] (UMLS (ICD9CM) C0157407) =Disease or Syndrome
| - 63. RETINA LAYER SEPARAT NOS
- [ ] (UMLS (ICD9CM) C0154844) =Acquired Abnormality
|
- 14. RETAIN PLACENTA NOS-UNSP
- [ ] (UMLS (ICD9CM) C0157405) =Disease or Syndrome
| - 64. RETINA MICROANEURYSM NOS
- [ ] (UMLS (ICD9CM) C0154834) =Disease or Syndrome
|
- 15. RETAIN PROD CONCEPT-UNSP
- [ ] (UMLS (ICD9CM) C0157409) =Disease or Syndrome
| - 65. retina photosensitive pigment
- [photopigments in retinal rods and cones that respond to certain colors of light and initiate the process of vision. ( CSP )] (UMLS (CSP) C0035323) =Organic Chemical; Biologically Active Substance =pigment;
=rhodopsin;
|
- 16. Retained (old) intraocular foreign body, nonmagnetic
- (UMLS (ICD9CM) C0271015) =Finding ;
| - 66. RETINA VENOUS ENGORGEMNT
- [ ] (UMLS (ICD9CM) C0154843) =Finding
|
- 17. RETAINED DENTAL ROOT
- [ ] (UMLS (ICD9CM) C0155952) =Disease or Syndrome ;
| - 67. retina visual transduction
- [ ] (UMLS (CSP) C0599622) =Mental Process
|
- 18. Retained placenta or membranes, without hemorrhage
- [ ] (UMLS (ICD9CM) C0157404) =Disease or Syndrome
| - 68. Retina, Tear(s) In
- [Perforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. The concept includes retinal breaks, tears, dialyses, and holes. ( MSH )] (UMLS (NCI) C0035321) =Acquired Abnormality; Disease or Syndrome =ANDRE NETTHINNESYKDOMMER - h35.0;
|
- 19. Retained placenta without hemorrhage
- [ ] (UMLS (ICD9CM) C0269905) =Pathologic Function ;
| - 69. retinal
- [biologically active form of vitamin A, which combines with certain proteins (opsins) to form visual pigments (e.g. rhodopsin); light absorption causes cis-trans isomerization of retinal, which is transduced by protein into neural signal and vision. ( CSP )] (UMLS (CSP) C0035331) =Organic Chemical; Vitamin ;
=Retinoic Acid Agent;
|
- 20. Retained placenta without hemorrhage, with delivery, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0157406) =Disease or Syndrome
| - 70. retinal adaptation
- [adjustment of the photoreceptor cell of the eye to the surrounding illumination. ( CSP )] (UMLS (CSP) C0178832) =Organ or Tissue Function ;
=Sight;
=dark adaptation;
light adaptation |
- 21. Retained portions of placenta or membranes, without hemorrhage
- [ ] (UMLS (ICD9CM) C0157408) =Disease or Syndrome
| - 71. Retinal Arteriovenous Malformation
- (UMLS (NCI) C0521570) =Congenital Abnormality ;
|
- 22. RETCLSRC UNSP XTRNDL ORG
- (UMLS (ICD9CM) C0375075) =Neoplastic Process
| - 72. Retinal Artery
- [Central retinal artery and its branches. It arises from the ophthalmic artery, pierces the optic nerve and runs through its center, enters the eye through the porus opticus and branches to supply the retina. ( MSH )] (UMLS (NCI) C0035301) =Body Part, Organ, or Organ Component ;
|
- 23. Rete Ovarii
- (UMLS (NCI) C0227880) =Body Part, Organ, or Organ Component
| - 73. Retinal Artery Occlusion
- [Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye. ( MSH )] (UMLS (NCI) C0035302) =Disease or Syndrome ;
=Arterial Occlusive Diseases;
ANDRE NETTHINNESYKDOMMER - h35.0 |
- 24. Rete Testis
- [The network of channels formed at the termination of the straight SEMINIFEROUS TUBULES in the mediastinum testis. Rete testis channels drain into the efferent ductules that pass into the caput EPIDIDYMIS. ( MSH )] (UMLS (NCI) C0035278) =Body Part, Organ, or Organ Component ;
| - 74. retinal bipolar neuron
- [retinal neuron that has two processes arising from opposite poles of the cell body. ( CSP )] (UMLS (CSP) C0597407) =Cell ;
=nerve cell;
Eye - Retina (MMHCC) |
- 25. Retention
- [The condition of remaining in a place or position or of holding within. ( NCI )] (UMLS (NCI) C0333117) =Functional Concept ;
| - 75. Retinal Cell Neoplasm
- (UMLS (NCI) C1335765) Retinal Cell Tumor =Neoplastic Process ;
|
- 26. Retention Cyst of Ovary
- (UMLS (NCI) C1368578) Retention Cyst of the Ovary;
Retention Ovarian Cyst =Finding | - 76. Retinal Defect
- (UMLS (NCI) C0154823) =Disease or Syndrome ;
|
- 27. Retention of urine
- [Accumulation of urine within the bladder because of the inability to urinate. ( NCI )] (UMLS (ICD9CM) C0080274) =Finding ;
=urination disorder;
| - 77. Retinal defects without detachment
- (UMLS (ICD9CM) C0700508) =Disease or Syndrome
|
- 28. retest
- [ Definition:The event occurred so that a test or observation performed at a prior event could be performed again due to conditions set forth in the protocol. ( HL7V3.0 )] (UMLS (HL7) C1698057) =Idea or Concept ;
=ActReason;
| - 78. Retinal Dystrophy
- (UMLS (NCI) C0854723) =Disease or Syndrome; Anatomical Abnormality
|
- 29. RETI
- [The determination of the number of reticulocytes in a blood sample. ( NCI )] (UMLS (NCI) C0206161) =Laboratory Procedure
| - 79. Retinal edema
- (UMLS (ICD9CM) C0242420) =Disease or Syndrome ;
|
- 30. Reticular Cell
- [A cell with processes making contact with those of other similar cells to form a cellular network sheathing a network of reticular fibers, which constitutes the stroma of all lymphoid organs except the thymus ( NCI )] (UMLS (NCI) C1179443) =Cell ;
| - 80. retinal ganglion
- [cells of the innermost nuclear layer of the retina, the ganglion cell layer, which project axons through the optic nerve to the brain; variable in size and in the shapes of their dendritic arbors, which are generally confined to the inner plexiform layer; a small subset of these cells act as photoreceptors and project to the suprachiasmatic nucleus, the location of the circadian clock, setting the circadian rhythm. ( CSP )] (UMLS (CSP) C0035316) =Cell ;
=ganglion;
Eye - Retina (MMHCC) |
- 31. Reticular Dysgenesis
- (UMLS (NCI) C0272167) =Disease or Syndrome
| - 81. RETINAL ISCHEMIA
- [ ] (UMLS (ICD9CM) C0162291) =Disease or Syndrome
|
- 32. Reticular Fiber
- [A scleroprotein fibril consisting mostly of type III collagen. Reticulin fibrils are extremely thin, with a diameter of between 0.5 and 2 um. They are involved in maintaining the structural integrity in a variety of organs. ( MSH )] (UMLS (NCI) C0035285) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 82. RETINAL NEOVASCULAR NOS
- [Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina. ( MSH )] (UMLS (ICD9CM) C0035320) =Pathologic Function ;
=Neoangiogenesis;
ANDRE NETTHINNESYKDOMMER - h35.0 |
- 33. reticular formation
- [area in the tegmentum of the midbrain and pons and its continuation into the medulla and upper spinal cord, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network. ( CSP )] (UMLS (CSP) C0035284) =Body Part, Organ, or Organ Component ;
=hind brain;
| - 83. RETINAL NERV FIBER DEFEC
- [ ] (UMLS (ICD9CM) C0474334) =Disease or Syndrome ;
|
- 34. Reticulin Fibrosis of the Bone Marrow
- (UMLS (NCI) C1335762) =Finding ;
| - 84. Retinal Pigment Epithelium
- [epithelium in the retina, ciliary body, and iris containing pigment granules. ( CSP )] (UMLS (NCI) C0035322) =Body Part, Organ, or Organ Component ;
=Epithelial Tissue;
EYE |
- 35. Reticulin stain
- [Stain, Reticulin ( HL7V3.0 )] (UMLS (HL7) C1294006) =Laboratory Procedure =ObservationMethod;
| - 85. retinal reductase
- [ ] (UMLS (CSP) C0248685) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 36. Reticuloendothelial Hyperplasia
- [hyperplasia of reticuloendothelial tissue. ( CSP )] (UMLS (NCI) C0035288) =Neoplastic Process ;
=lymphoma;
histiocytic lymphoma =familial splenic anemia;
Histiocytic Infiltrate;
Malignant mast cell tumors | - 86. retinal regeneration
- [ ] (UMLS (CSP) C0598425) =Cell Function ;
|
- 37. reticuloendothelial stimulant
- [ ] (UMLS (CSP) C0599481) =Chemical Viewed Functionally
| - 87. retinal screening pigment
- [ ] (UMLS (CSP) C0599342) =Body Part, Organ, or Organ Component ;
|
- 38. reticuloendothelial system
- [mononuclear phagocyte system (monocytes and macrophages) plus the vascular endothelium and the reticular and dendritic cells of lymphoid organs; whether this heterogeneous collection can still be considered a "system" is controversial. ( CSP )] (UMLS (CSP) C0035287) =Body System ;
=lymphatic tissue;
| - 88. RETINAL TELANGIECTASIA
- [ ] (UMLS (ICD9CM) C0154835) =Disease or Syndrome
|
- 39. Reticuloendothelial System, Spleen
- [glandlike ductless organ situated in the upper abdominal cavity; it gives rise to new red blood cells in fetus and newborn, disintegrates red blood cells, serves as a blood reservoir, and produces lymphocytes and plasma cells. ( CSP )] (UMLS (NCI) C0037993) =Body Part, Organ, or Organ Component ;
=lymphatic tissue;
Body Part | - 89. RETINAL TRACTION DETACH
- [ ] (UMLS (ICD9CM) C0154828) =Acquired Abnormality
|
- 40. Reticuloendothelial System, Thymus
- [single, unpaired primary lymphoid organ situated in the mediastinum; it is necessary for normal development of immunologic function early in life but by puberty it begins to involute and much of the tissue is replaced by fat. ( CSP )] (UMLS (NCI) C0040113) =Body Part, Organ, or Organ Component =Body System, Endocrine/Metabolic;
lymphatic tissue;
Body Part;
| - 90. RETINAL VASC OCCLUS NOS
- (UMLS (ICD9CM) C0035326) =Disease or Syndrome ;
|
- 41. Reticulohistiocytic Granuloma
- [A rare cutaneous lesion composed of eosinophilic histiocytes, which are often multinucleated. The lesions are yellow-brown papules affecting any part of the body. Patients are usually adult men. The prognosis is excellent. — 2003 ( NCI )] (UMLS (NCI) C0035290) =Neoplastic Process ;
| - 91. Retinal vasculitis
- [Inflammation of the retinal vasculature with various causes including infectious disease; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; BEHCET SYNDROME; and CHORIORETINITIS. ( MSH )] (UMLS (ICD9CM) C0152026) =Disease or Syndrome
|
- 42. Reticulon 1 Gene
- [This gene plays a protein trafficking and is involved in exocytosis. ( NCI )] (UMLS (NCI) C1335653) RTN1;
RTN1 Gene =Gene or Genome ;
| - 92. Retinal Vein
- [Central retinal vein and its tributaries. It runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus. ( MSH )] (UMLS (NCI) C0035327) =Body Part, Organ, or Organ Component
|
- 43. Reticulon 4 Gene
- [This gene plays a role in cell organization/biogenesis. ( NCI )] (UMLS (NCI) C1366527) RTN4;
RTN4 Gene =Gene or Genome | - 93. Retinal Vein Occlusion
- [Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES. ( MSH )] (UMLS (NCI) C0035328) =Disease or Syndrome =ANDRE NETTHINNESYKDOMMER - h35.0;
venous thrombosis |
- 44. RETICULOSARCOMA ABDOM
- [ ] (UMLS (ICD9CM) C0153698) =Neoplastic Process
| - 94. retinitis
- [inflammation of the retina. ( CSP )] (UMLS (CSP) C0035333) =Disease or Syndrome =ANDRE NETTHINNESYKDOMMER - h35.0;
=chorioretinitis;
CMV retinitis;
chorioretinitis;
Retinal Necrosis Syndrome, Acute;
CMV retinitis;
|
- 45. RETICULOSARCOMA AXILLA
- [ ] (UMLS (ICD9CM) C0153699) =Neoplastic Process
| - 95. retinitis pigmentosa
- [group of inherited abnormalities in the retina; characterized by night blindness, retinal atrophy, weakening of the retinal vessels, pigment clumping, and contraction of the visual field. ( CSP )] (UMLS (CSP) C0035334) =Disease or Syndrome =Eye Diseases, Hereditary;
Genetic Condition;
Degeneration of retina;
=Usher syndrome;
Kearns Syndrome |
- 46. RETICULOSARCOMA HEAD
- [ ] (UMLS (ICD9CM) C0153696) =Neoplastic Process
| - 96. retinoate
- [oxidixed derivative of retinaldehyde, naturally occurring or synthetic; the drugs tretinoin (all-trans isomer) and isotretinoin (13- cis isomer) are listed by USP as a keratolytics; both are used in anti- acne/anti-wrinkle skin creams. ( CSP )] (UMLS (CSP) C0178833) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =Retinoic Acid Agent;
=13 cis retinoate;
|
- 47. RETICULOSARCOMA INGUIN
- [ ] (UMLS (ICD9CM) C0153700) =Neoplastic Process
| - 97. retinoate receptor
- [ ] (UMLS (CSP) C0599343) =Amino Acid, Peptide, or Protein; Receptor
|
- 48. Reticulosarcoma involving intrapelvic lymph nodes
- [ ] (UMLS (ICD9CM) C0153701) =Neoplastic Process
| - 98. Retinocytoma
- (UMLS (NCI) C0346396) =Neoplastic Process
|
- 49. Reticulosarcoma involving intrathoracic lymph nodes
- [ ] (UMLS (ICD9CM) C0153697) =Neoplastic Process
| - 99. retinography
- [photography of the retina. ( CSP )] (UMLS (CSP) C0597408) =Diagnostic Procedure ;
=eye disorder diagnosis;
imaging/visualization/scanning =electroretinogram |
- 50. Reticulosarcoma involving lymph nodes of multiple sites
- [ ] (UMLS (ICD9CM) C0153703) =Neoplastic Process
| - 100. Retinoic Acid Agent
- [retinol and its derivatives; C(20) polyunsaturated, cyclic, lipid soluble alcohol; deficiency results in night blindness and certain epithelial disorders. ( CSP )] (UMLS (NCI) C0035339) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =carotenoid;
diterpene;
terpene;
[VT000] VITAMINS =retinal;
4-(all-trans-retino-yl)aminophenol;
3,7-Dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol;
retinoate;
(2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid, Ethyl Ester;
13 cis retinoate;
[VT050] VITAMIN A;
(All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid;
3-methyl TTNEB;
|
home
